0.4620
-0.0100
(-2.12%)
At close: January 10 at 2:23:37 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 52.5M |
| Low Estimate | -- | -- | -- | 52.5M |
| High Estimate | -- | -- | -- | 52.5M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANNX.ST | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
SOFTX.OL SoftOx Solutions AS
0.0154
+10.00%
COMBI.ST CombiGene AB (publ)
2.5200
+2.44%
CYXO.ST Cyxone AB (publ)
0.0180
0.00%
QUIA.ST Quia Pharma AB (publ)
0.0106
-0.93%
IMMU.ST Mendus AB (publ)
8.20
0.00%
KDEV.ST Karolinska Development AB (publ)
1.0000
+0.30%
NANECH.ST NanoEcho AB
0.2025
-1.46%
GENO.ST Genovis AB (publ.)
24.65
+0.41%
ZICC.ST Ziccum AB (publ)
0.2500
0.00%
ALZ.ST Alzinova AB (publ)
3.2800
-2.38%